An investigation of fecal volatile organic metabolites in irritable bowel syndrome.
Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to invasive investigations in order to rule out other diseases and reassure their patients. Volatile organic metabolites (VOMs) are emitted from feces; understanding changes in the patterns of these VOMs could aid o...
Guardado en:
Autores principales: | Iftikhar Ahmed, Rosemary Greenwood, Ben de Lacy Costello, Norman M Ratcliffe, Chris S Probert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6e2474676cd4438a4e43397e09a30ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The fecal mycobiome in patients with Irritable Bowel Syndrome
por: A. Das, et al.
Publicado: (2021) -
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021) -
The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018) -
Five personality dimensions in patients with irritable bowel syndrome
por: Alireza Farnam, et al.
Publicado: (2008) -
The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome
por: Alina A. Makarova, et al.
Publicado: (2021)